Press Releases

09.14.2022

Pfizer Invites Public to View and Listen to Webcast of Analyst and Investor Call to Review Oral GLP-1 Data Presented at European Association for the Study of Diabetes (EASD) 2022

09.06.2022

Pfizer Invites Public to View and Listen to Webcast of Pfizer Discussion at Healthcare Conference

09.06.2022

Pfizer Invites Public to View and Listen to a Webcast of Pfizer Discussion on Climate Action

09.01.2022

Pfizer Invites Public to View and Listen to Two Webcasts of Pfizer Discussions at Healthcare Conferences

08.19.2022

Pfizer Invites Public to View and Listen to Webcast of Pfizer Discussion at Healthcare Conference

08.08.2022

Pfizer to Acquire Global Blood Therapeutics for $5.4 Billion to Enhance Presence in Rare Hematology

07.28.2022

PFIZER REPORTS SECOND-QUARTER 2022 RESULTS

06.28.2022

Roivant and Pfizer Unveil Priovant Therapeutics and Ongoing Registrational Studies for Oral Brepocitinib in Dermatomyositis and Lupus

06.24.2022

Pfizer Invites Public to View and Listen to Webcast of July 28 Conference Call with Analysts

06.23.2022

Valneva and Pfizer Announce Closing of Equity Investment

06.23.2022

Pfizer Declares Third-Quarter 2022 Dividend

06.09.2022

Pfizer Completes Acquisition of ReViral